BIP
CYTK icon

Brandes Investment Partners’s Cytokinetics CYTK Stock Holding History

Brandes Investment Partners’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-18,300
Closed -$191K – 188
2015
Q4 		$191K Hold
18,300
– – ﹤0.01% 151
2015
Q3 		$122K Hold
18,300
– – ﹤0.01% 158
2015
Q2 		$123K Hold
18,300
– – ﹤0.01% 164
2015
Q1 		$124K Buy
+18,300
New +$137K ﹤0.01% 155

Other funds holding CYTK

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Brandes Investment Partners's CYTK Position: Q1 2016 in Review

Brandes Investment Partners sold out of Cytokinetics (CYTK) in Q1 2016, closing a stake of 18,300 shares — an estimated $191K sold.

Brandes Investment Partners first reported a position in CYTK in Q1 2015 and held it in 4 quarters. The position peaked at $191K in Q4 2015. 109 funds tracked by Wall St. Rank hold CYTK as of Q1 2016.

  • Brandes Investment Partners reported no remaining Cytokinetics position as of Q1 2016 after selling out during the quarter.
  • Brandes Investment Partners sold 18,300 Cytokinetics shares in Q1 2016, an estimated $191K.
  • Brandes Investment Partners first reported a position in Cytokinetics in Q1 2015 and held it in 4 quarters.
  • Brandes Investment Partners's Cytokinetics position peaked at $191K in Q4 2015.
  • 109 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2016.

Based on Brandes Investment Partners's 13F filing for Q1 2016, filed 12 May 2016.